Your browser doesn't support javascript.
loading
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.
Ortega-Ferreira, Céline; Soret, Perrine; Robin, Gautier; Speca, Silvia; Hubert, Sandra; Le Gall, Marianne; Desvaux, Emiko; Jendoubi, Manel; Saint-Paul, Julie; Chadli, Loubna; Chomel, Agnès; Berger, Sylvie; Nony, Emmanuel; Neau, Béatrice; Fould, Benjamin; Licznar, Anne; Levasseur, Franck; Guerrier, Thomas; Elouej, Sahar; Courtade-Gaïani, Sophie; Provost, Nicolas; Nguyen, The Quyen; Verdier, Julien; Launay, David; De Ceuninck, Frédéric.
Affiliation
  • Ortega-Ferreira C; Servier R&D Center, Biomarker Assay Development, Translational Medicine, Gif-sur-Yvette, France.
  • Soret P; Servier R&D Center, Biomarker Biostatistics, Gif-sur-Yvette, France.
  • Robin G; Mabqi SAS, Montpellier, France.
  • Speca S; U1286 INFINITE, Institute for Translational Research in Inflammation, Lille University, Gif-sur-Yvette, France.
  • Hubert S; Inserm, Lille, France.
  • Le Gall M; Servier R&D Center, Neurosciences and Immuno-inflammation Therapeutic Area, Gif-sur-Yvette, France.
  • Desvaux E; Mabqi SAS, Montpellier, France.
  • Jendoubi M; Servier R&D Center, Neurosciences and Immuno-inflammation Therapeutic Area, Gif-sur-Yvette, France.
  • Saint-Paul J; U1286 INFINITE, Institute for Translational Research in Inflammation, Lille University, Gif-sur-Yvette, France.
  • Chadli L; Inserm, Lille, France.
  • Chomel A; Mabqi SAS, Montpellier, France.
  • Berger S; Servier R&D Center, Clinical Biomarker Development, Translational Medicine, Gif-sur-Yvette, France.
  • Nony E; Servier R&D Center, Protein Sciences, Gif-sur-Yvette, France.
  • Neau B; Servier R&D Center, Structural Sciences, Gif-sur-Yvette, France.
  • Fould B; Servier R&D Center, Protein Sciences, Gif-sur-Yvette, France.
  • Licznar A; Servier R&D Center, Preclinical Biostatistics, Quantitative Pharmacology, Gif-sur-Yvette, France.
  • Levasseur F; Servier R&D Center, Protein Sciences, Gif-sur-Yvette, France.
  • Guerrier T; Servier R&D Center, DMPK Department, Translational Medicine, Gif-sur-Yvette, France.
  • Elouej S; Servier R&D Center, DMPK Department, Translational Medicine, Gif-sur-Yvette, France.
  • Courtade-Gaïani S; U1286 INFINITE, Institute for Translational Research in Inflammation, Lille University, Gif-sur-Yvette, France.
  • Provost N; Inserm, Lille, France.
  • Nguyen TQ; Servier R&D Center, Computational Medicine, Gif-sur-Yvette, France.
  • Verdier J; Servier R&D Center, Computational Medicine, Gif-sur-Yvette, France.
  • Launay D; Servier R&D Center, Molecular Genomics, Gif-sur-Yvette, France.
  • De Ceuninck F; Servier R&D Center, Structural Sciences, Gif-sur-Yvette, France.
Nat Commun ; 14(1): 5291, 2023 08 31.
Article in En | MEDLINE | ID: mdl-37652913
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Galectin 3 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Galectin 3 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: France Country of publication: United kingdom